Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1): Randomized, Double-Blind, Placebo-Controlled Phase 2 Dose-Finding Trial

By R. Macdonald, N. Kassell, S. Mayer, D. Ruefenacht, P. Schmiedek, S. Weidauer, A. Frey, S. Roux, A. Pasqualin. Stroke, 2008

628 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Neurology

View Paper: https://www.semanticscholar.org/paper/157914a1a39fe90d11230a9ea65dff2b96f26c72

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

1. J. Dreier

Citations in the corpus

• Clinical Relevance of Cortical Spreading Depression in Neurological Disorders: Migraine, Malignant Stroke, Subarachnoid and Intracranial Hemorrhage, and Traumatic Brain Injury (2011, background): “Delayed cerebral ischemia shows peak occurrence around day 7 and develops in about 25% of patients surviving the initial hemorrhage (Macdonald et al, 2008).”